DETAILS OF ETHICS APPROVAL:
The primary study was approved by the institutional review board at each clinical site and the data coordinating center. The secondary analysis was approved by the University of Pittsburgh Institutional Review Board (no. 13110579). Initial approval date: 2 February 2014. Final approval date: 6 November 2019.